PPD strengthens its presence in Eastern Europe

Published: 24-Jun-2008
Media

US-based global contract research organisation PPD is to open an office in Istanbul, Turkey, continuing the company's growth of its Phase II-IV clinical development services in Eastern Europe. PPD will provide clinical monitoring services in key therapeutic areas from this location.


US-based global contract research organisation PPD is to open an office in Istanbul, Turkey, continuing the company's growth of its Phase II-IV clinical development services in Eastern Europe. PPD will provide clinical monitoring services in key therapeutic areas from this location.

The new office strengthens PPD's presence in Eastern Europe beyond Russia and Ukraine, countries where the company is expanding through its pending acquisition of InnoPharm. Eastern Europe is an important, high-growth market for clinical trials and a region PPD has targeted for expansion.

"With a population of 74 million people, Turkey is becoming an attractive place to conduct clinical trials," said Fred Eshelman, ceo of PPD. "Eastern Europe offers recruitment opportunities and quality investigators, and our Istanbul office is an important part of our strategic growth in this region."

  • Companies:
  • PPD
See more

You may also like

Media

PPD opens lab in Singapore and confirms InnoPharm acquisition

Read more
PPD, a US-based global contract research organisation, plans to expand its laboratory services into Singapore in response to growing demand in South-east Asia.

Trending Articles

  1. SGD Pharma announces the appointment of Fabio Invernizzi, General Manager West Business Unit The BU West includes SGD Pharma’s commercial activities for MEA, North and South America and our manufacturing footprint in Europe
  2. You need to be a subscriber to read this article.
    Click here to find out more.
    Slovakia: the pharmaceutical market’s best kept secret? Pharmaceutical manufacturing in Europe
  3. GEA Pharma & Healthcare share company updates at CPHI Barcelona Jim Holman, Technology Management Senior Director at GEA Pharma & Healthcare, discusses the company's recent endeavours to enhance the sustainability of their manufacturing procedures, the development of their novel tablet press range and the digital Canary system
  4. You need to be a subscriber to read this article.
    Click here to find out more.
    Pharmaceutical patent issues in Indonesia Indonesia is South East Asia’s largest pharmaceutical market and its Ministry of Health has been actively looking to lower prices and attract more investment in the sector. Viewed within this context, it is clear that Indonesia’s 2016 patent law is set to have a major impact on the nation’s burgeoning pharmaceutical industry
  5. Optimising excipients to improve bioavailability Guy Tiene, Director of Strategic Content, That's Nice LLC/Nice Insight, discusses excipient market trends, the use of excipients to improve the poor aqueous solubility of increasingly complex drug candidates and how drug developers choose excipient suppliers

Upcoming event

ASGCT Annual Meeting 2024

7-11 May, 2024 | Meeting | Portland, OR See all

You may also like

Media

PPD opens lab in Singapore and confirms InnoPharm acquisition

<p>PPD, a US-based global contract research organisation, plans to expand its laboratory services into Singapore in response to growing demand in South-east Asia.</p>
Media

Curia receives 2024 CDMO leadership award

Curia recognised for its service in the CDMO industry
Media

Biovian and 3P Biopharmaceuticals join forces to create 3PBIOVIAN

Biovian and 3P Biopharmaceuticals, two leading biologics CDMOs, announce their combination to establish a new pan-European leader in their field
Media

Royal Society of Chemistry and TIB co-create next generation Open Access consortium model

The agreement delivers shared goals of equity for institutions, a community approach and universal open access for authors
Media

Thermo Fisher launches industry’s first off-the-shelf solution to streamline and automate cell therapy manufacturing

Gibco CTS Cellmation Software digitally connects instruments from across Thermo Fisher’s cell therapy portfolio to streamline and automate manufacturing
Media

Two new appointed members have joined the RSC’s Board of Trustees

The dual appointment will add invaluable commercial acumen and project leadership experience
Media

India pharma growth expectations in 2024 are the highest globally, say CPHI & PMEC India

More than 60% of the executives here are "highly positive" about 2024 — the highest of any country
Subscribe now